Is On Investors’ Radar Today Royalty Pharma (RPRX) has been drawing attention after recent share performance and updated ...

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence ("AI") platform with the ...

NEWTOWN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing oral small molecule ...

We recently compiled a list of the 12 AI Stocks Making Headlines: Latest News and Ratings. In this article, we are going to take a look at where IGC Pharma, Inc. (NYSEAMERICAN:IGC) stands against the ...

Hybrid Trial Model Enhances Participant Access, Retention, and Enrollment Efficiency Across Underserved and Rural Communities ...

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

Traditionally, medtech companies have utilized a sales-based model, but many of them are now transitioning to recurring-revenue models like subscription-based services or device-as-a-service. The need ...

PHILADELPHIA--(BUSINESS WIRE)--Big Pharma's dependence on traditional executive compensation plans threatens to work in opposition to the very "medicine" of innovation that could restore the sector's ...

To Sharpen Focus on the Global Commercialization of Strategic Products and the External Partnership Model, LEO Pharma Makes Changes to Leadership NOT INTENDED FOR UK MEDIA At LEO Pharma, we have made ...

Substantial changes in disease progression were observed after a single oral dose of tivoxavir marboxil in the ferret model of bird flu using the A/Texas/37/2024 H5N1 virus isolated from an infected ...